All opioid equivalencies should be considered approximations only and can be affected by interpatient variability, type of pain (eg, acute vs. chronic), chronic administration, tolerance, etc.

Your support goes further this holiday season. When you buy an annual membership or give a one-time contribution, we’ll give a membership to someone who can’t afford access. It’s a simple way for you ...

(MENAFN- PR Newswire) MIAMI, Nov. 9, 2021 /PRNewswire/ -- Today, VITAS Healthcare, the nation's leading provider of end-of-life care, launched the industry's first comprehensive opioid conversion tool ...

Andrew Kolodny receives funding from the United States Food and Drug Administration for research on prescription drug monitoring programs. He is also the director of Physicians for Responsible Opioid ...